A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Mitapivat in Patients with Sickle Cell Disease

被引：2
|
作者：
Howard, Joanna [1 ]
Kuo, Kevin H. M. [2 ]
Oluyadi, Abdulafeez [3 ]
Shao, Hui [3 ]
Morris, Susan [3 ]
Zaidi, Ahmar U. [3 ]
Van Beers, Eduard J. [4 ]
Thien, Swee Lay [5 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Dept Hematol, London, England
[2] Univ Toronto, Div Med Oncol & Hematol, Toronto, ON, Canada
[3] Agios Pharmaceut Inc, Cambridge, MA USA
[4] Univ Med Ctr Utrecht, Creveldkliniek Dept Internal Med, Utrecht, Netherlands
[5] Natl Heart Lung & Blood Inst, Natl Inst Hlth, Sickle Cell Branch, Bethesda, MD USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3109
引用
收藏
页数：5
相关论文
共 50 条
  • [1] A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of Mitapivat in Patients with Sickle Cell Disease: RISE UP Phase 2 Results
    Idowu, Modupe
    Otieno, Lucas
    Dumitriu, Bogdan
    Lobo, Clarisse L. C.
    Thein, Swee Lay
    Andemariam, Biree
    Nnodu, Obiageli E.
    Inati, Adlette
    Glaros, Alexander K.
    Olalla Saad, Sara Teresinha
    Bartolucci, Pablo
    Colombatti, Raffaella
    Taher, Ali T.
    Abboud, Miguel R.
    Oluyadi, Abdulafeez
    Iyer, Varsha
    Yin, Ophelia
    Morris, Susan
    Yates, Amber M.
    Shao, Hui
    Patil, Spurthi
    Urbstonaitis, Rolandas
    Zaidi, Ahmar U.
    Smith, Wally R.
    [J]. BLOOD, 2023, 142
  • [2] Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial
    Lizarralde-Iragorri, Maria A.
    Gopalan, Bindu Parachalil
    Merriweather, Brenda
    Brooks, Jennifer
    Hill, Mai
    Lovins, Dianna
    Pierre-Charles, Ruth
    Cullinane, Ann
    Dulau-Florea, Alina
    Lee, Duck-Yeon
    Villasmil, Rafael
    Jeffries, Neal
    Shet, Arun S.
    [J]. BLOOD ADVANCES, 2024, 8 (01) : 172 - 182
  • [3] Safety and Pharmacokinetics of Recombinant ADAMTS13 in Patients with Sickle Cell Disease: A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study
    Kanter, Julie
    Patwari, Parth
    Desai, Payal
    Ataga, Kenneth I.
    Crary, Shelley E.
    Lanzkron, Sophie
    Field, Joshua
    Chung, Yu-Che
    Wang, Linda T.
    Mellgard, Bjorn
    Van Anh Nguyen
    Gordeuk, Victor R.
    [J]. BLOOD, 2023, 142
  • [4] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    [J]. NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [5] A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
    Wun, Ted
    Soulieres, Denis
    Frelinger, Andrew L.
    Krishnamurti, Lakshmanan
    Novelli, Enrico M.
    Kutlar, Abdullah
    Ataga, Kenneth I.
    Knupp, Charles L.
    McMahon, Lillian E.
    Strouse, John J.
    Zhou, Chunmei
    Heath, Lori E.
    Nwachuku, Chuke E.
    Jakubowski, Joseph A.
    Riesmeyer, Jeffrey S.
    Winters, Kenneth J.
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [6] A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
    Ted Wun
    Denis Soulieres
    Andrew L Frelinger
    Lakshmanan Krishnamurti
    Enrico M Novelli
    Abdullah Kutlar
    Kenneth I Ataga
    Charles L Knupp
    Lillian E McMahon
    John J Strouse
    Chunmei Zhou
    Lori E Heath
    Chuke E Nwachuku
    Joseph A Jakubowski
    Jeffrey S Riesmeyer
    Kenneth J Winters
    [J]. Journal of Hematology & Oncology, 6
  • [7] Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
    Butchart, Joseph
    Brook, Laura
    Hopkins, Vivienne
    Teeling, Jessica
    Puentener, Ursula
    Culliford, David
    Sharples, Richard
    Sharif, Saif
    McFarlane, Brady
    Raybould, Rachel
    Thomas, Rhodri
    Passmore, Peter
    Perry, V. Hugh
    Holmes, Clive
    [J]. NEUROLOGY, 2015, 84 (21) : 2161 - 2168
  • [8] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIAL
    Tufan, Ayse N.
    Tufan, Fatih
    [J]. NEUROLOGY, 2015, 85 (23) : 2083 - 2084
  • [9] Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study
    Uchimura, Naohisa
    Taniguchi, Mitsutaka
    Ariyoshi, Yu
    Oka, Yasunori
    Togo, Osamu
    Uchiyama, Makoto
    [J]. SLEEP MEDICINE, 2024, 122 : 27 - 34
  • [10] Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study
    Motoya, Satoshi
    Watanabe, Kenji
    Ogata, Haruhiko
    Kanai, Takanori
    Matsui, Toshiyuki
    Suzuki, Yasuo
    Shikamura, Mitsuhiro
    Sugiura, Kenkichi
    Oda, Kazunori
    Hori, Tetsuharu
    Araki, Takahiro
    Watanabe, Mamoru
    Hibi, Toshifumi
    [J]. PLOS ONE, 2019, 14 (02):
12345